From another perspective, therapies that lower PTH levels to the recommended range have been linked to improved bone properties and fewer fractures in patients with secondary hyperparathyroidism [25], indicating that elevated PTH levels are detrimental to bone health in dialysis patients. Here, PTH is linked to secondary hyperparathyroidism.